Dan Zang
- Molecular Biology
- Oncology top 10%
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine
- Immunology
- Topics
- Cancer-related molecular mechanisms research (5 papers)Gut microbiota and health (5 papers)MicroRNA in disease regulation (4 papers)
- Journals
- PLoS ONEOncogeneJournal of Virology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Dan Zang
36 papers receiving 792 citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Molecular Biology 486
- Oncology 237
- Cancer Research 166
- Pulmonary and Respiratory Medicine 115
- Immunology 68
Countries citing papers authored by Dan Zang
This map shows the geographic impact of Dan Zang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Zang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Zang more than expected).
Fields of papers citing papers by Dan Zang
This network shows the impact of papers produced by Dan Zang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Zang. The network helps show where Dan Zang may publish in the future.
Co-authorship network of co-authors of Dan Zang
This figure shows the co-authorship network connecting the top 25 collaborators of Dan Zang. A scholar is included among the top collaborators of Dan Zang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Zang. Dan Zang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic (Review)breakdown → | 61 |
| 5 | 21 | |
| 6 | 14 | |
| 7 | 8 | |
| 8 | 12 | |
| 9 | 13 | |
| 10 | 12 | |
| 11 | 9 | |
| 12 | 34 | |
| 13 | 9 | |
| 14 | 14 | |
| 15 | 19 | |
| 16 | 18 | |
| 17 | 21 | |
| 18 | 26 | |
| 19 | 32 | |
| 20 | 10 |
About Dan Zang
Dan Zang is a scholar working on Biological Psychiatry, Cancer Research and Genetics, having authored 39 papers that have together received 804 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Gut microbiota and health (5 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (166 citations), Oncology (237 citations) and Molecular Biology (486 citations). Dan Zang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jun Chen, Chong Zhao, Xianping Shi, Xuejun Wang, Xin Chen, Xiaoying Lan, Hongbiao Huang, Jinbao Liu, Ningning Liu and Shiqian Chen. Their work appears in journals such as PLoS ONE, Oncogene and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.